-The Hindu In seeking to pursue conflicting objectives, the policy architecture is complex and difficult to implement Contrary to popular perception, public policies are made without full knowledge or facts. More often than not, they embody assumptions arising from experience, an understanding of history, and present conditions. Considering the vast sea of unknowns surrounding COVID-19, it would be understandable to place a greater reliance on historical experience. Instead, India’s vaccine policy appears...

-PTI/ Business Standard The findings of the study are under consideration for publication in a peer-reviewed medical journal A multi-centre study on a cohort of over 31,000 vaccinated healthcare workers of a leading private facility, spanning across the country, has found that Covid vaccine provided protection against infection in "95 per cent" of the beneficiaries, hospital authorities claimed on Wednesday. The study by Apollo Hospitals took place over four and a half months,...

-Newsclick.in Large-scale privatisation of the vaccination programme is happening, cutting of low-paying sections of the population. Yet, other discrepancies remain, calling for an audit by CAG. India is facing an acute vaccine shortage. The impression that generally prevails is that this shortage is because while production capacity is slow to increase, there has been a sudden spurt in vaccine demand since vaccination is now open for the 18-44 years age group in...

-The Hindu Vaccine gifts of 2-3 million doses may have little impact on India: officials The government on Friday welcomed the U.S. decision to lift restrictions under its Defence Production Act on the export of vaccine ingredients to AstraZeneca vaccine manufacturers worldwide, which would help the Serum Institute of India produce more doses. However, Washington’s announcement of gifting India and dozens of other countries with a first tranche of 25 million doses of...

-The Hindu/ PTI If the containment measures, COVID-19 appropriate behaviour or vaccination pace slackens, cases can rise again, it said. India has to buy time to ensure that high coverage of vaccination against COVID-19 is achieved, the government said on Friday. If the containment measures, COVID-19 appropriate behaviour or vaccination pace slackens, cases can rise again, it said. Data sharing is going on with the WHO to give recognition to Bharat Biotech's COVAXin, the...